Ann: IHL Receives Ethics Approval BA/BE Clinical Trial., page-7

Hey mate,

I can understand the IHL-42X landscape can be a little confusing with two pending trials

IHL-42x will be studied in two separate trials done in parallel.

>> BA/BE study in South Australia at the C-MAX facility has received HREC approval today to commence.

>> Phase 2/3 Trial in Europe & USA with up to 400 participants over 45 trial locations
https://stocknessmonster.com/announcements/ihl.asx-3A620063/ (Latest trial update)

Each trial is independent of the other, so HREC approval today for the BA/BE study.

If the HREC approval was not granted/declined it would have created some uncertainty, as the BA/BE study will be instrumental in the longer term.
As @kingkev said it's another box ticked on the journey.

The BOD is getting all their ducks aligned for IHL-42X,
we are expecting the IND filing for IHL-42x (phase 2/3 Trial - under FDA supervision) to eventuate in the coming days/weeks
and this BA/BE study will complement and support the eventual NDA application once the phase 2/3 Trial is completed.

Good luck @Hangover